Home
5452 All Specialties
1421 Arthroplasty
536 Shoulder & Elbow
504 Sports Medicine
499 Spine
492 Trauma
476 Osteoarthritis
476 Physical Therapy & Rehab
291 Foot & Ankle
286 General Orthopaedics
254 Hand & Wrist
79 Metabolic Disorders
69 Pediatric Orthopaedics
48 Cannabis
21 Tumour
OE Plus
7 Ace Reviews
1 OE Recommends
89 OE Originals
77 OrthoPODS
24 OE World Tour NEW
26 OE Perspectives
43 Conferences
149 Exclusive Interviews
15 Evidence Series
CME
PeerView
Orthopaedic Surgeon
Primary Care Physician
Physiotherapist
Occupational Therapist
Sports Medicine Specialist
Orthopaedic Resident/Intern
Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Loading...
Search Filters

Date Range

to

Report Types

ALL
RCT
META
ACE Reviews

Specialties

See all (14)

Emerging Treatments

OE Recommends Topics

Multimedia

Journal

Conference Series

Evidence Series

We found 1 results matching your search query: "Algeta"

Showing 1 - 1 of 1
Read Ace Report

Early vs standard zoledronic acid treatments for prostate cancer metastatic to bone

J Clin Oncol. 2014 Apr 10;32(11):1143-50. doi: 10.1200/JCO.2013.51.6500.

RCT Tumour Metastasis Algeta Amgen Aventis Bayer EXINI Diagnostics Novartis Sanofi Zoledronic Acid - Hide
Showing 1 - 1 of 1